Case Law Details
Case Name : Makson Pharma Ceuticals (India) Private Limited Vs PCIT (ITAT Ahmedabad)
Related Assessment Year : 2020-21
Courts :
All ITAT ITAT Ahmedabad
Become a Premium member to Download.
If you are already a Premium member, Login here to access.
Makson Pharma Ceuticals (India) Private Limited Vs PCIT (ITAT Ahmedabad)
Second opinion not allowed under 263: ITAT Ahmedabad quashes PCIT revision on depreciation, 14A & CSR-80G
Ahmedabad ITAT allowed the Assessee’s appeal and quashed the revision order passed u/s 263, holding that the PCIT had merely substituted his own view for that of the Assessing Officer, which is impermissible in law.
The PCIT had set aside the assessment u/s 143(3) r.w.s. 144B alleging lack of enquiry on four issues—(i) excess depreciation on residential building, (ii) excess depreciation on plant &...
This is premium content. Please become a Premium member. If you are already a member, login here to access the full content.
Kindly Refer to
Privacy Policy &
Complete Terms of Use and Disclaimer.


